BBK Worldwide^® Blog

Getting Decentralized Right

What Matters to Patients

We know the industry is ready to embrace decentralized clinical trials. But what about patients? What do they think about decentralized clinical trials? What elements are important to them? And what should sponsors consider when designing such trials?

To dig deep, we spoke one-on-one with Phil Kelly, a bladder cancer patient and advocate. He shares his experience and insight in Part 1 of this two-part series on the patient perspective.

Each year members of the industry gather together at Dpharm — a conference which challenges attendees to question how we, as an industry, can disrupt clinical research to reduce the burden to patients and physicians. This year's event will be held virtually September 28-29 and will focuses on making innovation stick in a post-COVID world.

Think You Know Us? Take Another Look!

View our 2021 Lookbook.

We leverage empathy and care as we get to the heart of the patient experience and what it means to be a study participant in today’s rapidly changing world.

One-on-One with BBK Worldwide® Director of
Tech Experience Dena Raffa 

There's no question that digital technology is changing the way we engage with patients and altering expectations for the patient experience. As part of our Pharma15 Live! series, we sat down with BBK's Director of Tech Experience Dena Raffa to get her perspective on current trends.

Raffa has been instrumental in many of BBK's software solutions and digital technologies, and most recently she has led the development of BBK's new patient engagement portal - a first of its kind for clinical trial participants.

Ever since legendary management consultant Peter Drucker famously declared that “culture eats strategy for breakfast,” strategy has suffered reputational damage. It’s time for a reputational restoration.

In the context of patient recruitment for clinical trials, strategy retains its centrality at BBK Worldwide®, serving as a fundamental catalyst of our award-winning marketing and creative efforts.

Create a Patient- and Site-Centric Environment for Decentralized Clinical Trials

Hear from the Experts! 

As decentralized clinical trials reshape the clinical research landscape, BBK Worldwide® Chief Innovation Officer Rob Laurens and Lead Concierge Alex Nicholl discuss efforts to help study sponsors embrace these trials with ease and confidence.

PHARMA15 LIVE!

Coordination to Creation: Initiating a New Study Partnership

We often hear about unburdening patients and site staff during clinical trial participation – but what about unburdening sponsors during the clinical trial lifecycle? As BBK Worldwide® Creative Director for Strategic Services, I assist in prescribing the programs and services that best align with the protocol to support a study’s participants on an individual basis. From there, my team and I work closely with our account executives to seamlessly bring our full-service study support from proposal to coordination to creation.

Meaningful Engagement at Critical Touchpoints along the Patient Journey

There's no better way to illustrate the importance of meaningful engagement than with the story of one family's journey from clinical trial awareness to participation. The story shows how the right mix of digital and physical touchpoints plays a critical role in creating a positive patient experience. The family's journey begins below.

New eBook Available for Download

As we continue to focus our attention on underserved populations, we've just released a content-rich eBook full of guidance that study sponsors can leverage to create a more diverse and inclusive clinical trial environment. It features a bonus section with excerpts from our recent Q&A with Michele Russell-Einhorn, chief compliance officer and institutional official at Advarra, that provide an IRB's perspective on improving diversity and inclusion in clinical trials.

Earlier this week, BBK Principal Rob Laurens went one-on-one with Outsourcing-Pharma discussing the launch of BBK's Engagement Solution Center for decentralized and post-marketing clinical trials, which features concierge service delivery and a robust patient experience portal to ease the clinical trial journey.

In this in-depth interview, Rob addresses the importance and advantages of centralizing design, management, operations, and communications of patient support services. In addition, he provides insight into some of the conversations that led to the creation of the center. Click here to read the full article.